MRNA Balita at Market Insights
Moderna is an American pharmaceutical and biotechnology company with headquarters in Massachusetts. Moderna rose to prominence during the Covid-19 pandemic as a primary candidate for developing a vaccine, which was then authorized for distribution to the public across multiple countries at the start of 2021. Moderna’s work focuses on drug discovery and development, heavily emphasizing artificial mRNA cells. Moderna stock is listed on the NASDAQ exchange and is also a constituent of the NASDAQ 100 index, a modified measure of the top 100 non-financial companies in the US on the exchange. Spread bet or trade CFDs on our Moderna share price.
Kaugnay ng Balita at Market Insights